Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 5;14(9):619.
doi: 10.3390/toxins14090619.

Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches

Katarzyna Kępczyńska  1 , Izabela Domitrz  1
Affiliations
Review

Botulinum Toxin-A Current Place in the Treatment of Chronic Migraine and Other Primary Headaches

Katarzyna Kępczyńska et al. Toxins (Basel). .

Abstract

Headaches are a very common condition that most people will experience many times during their lives. This article presents the primary headaches, which are a large group of diseases where the headache is not a symptom of another known disease. Tension-type headache affects approximately 80% of the general population, and the prevalence of migraine is estimated at 10-12%. Clinical data and experience to date have demonstrated that botulinum toxin may be an effective prophylactic treatment for chronic headache types. It has been used in neurology for the treatment of dystonia and blepharospasm. Now it has been approved to treat chronic migraine and has been shown to confer significant benefit in refractory cases. Based on clinical experience botulinum toxin has also been tried in other headache disorders. While it is intuitively attractive to think that due to its effect on pain by sensory modulation, there may also be efficacy in its use in chronic tension-type headache and cluster headache, so far, there is little evidence to support this. Botulinum toxin is effective in pain control through its interaction with the SNARE complex, which inhibits the release of neurotransmitters, such as glutamate, substance P and calcitonin gene-related peptide. OnabotulinumtoxinA is effective not only in headache frequency and pain intensity but in other parameters, including quality of life.

Keywords: botulinum toxin; chronic migraine; cluster headache; headaches; onabotulinumtoxinA; tension-type headache.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Frontalis and temporalis injections of botulinum toxin.
Figure 2
Figure 2
Posterior injections of botulinum toxin.
Figure 3
Figure 3
Follow the pain injection sites.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Headache Classification Commitee of the International Headache Society, International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38:1–211. doi: 10.1177/0333102417738202. - DOI - PubMed
    1. Bahra A., Evans R.W. The secondary Headaches. Cephalalgia. 2021;41:427–430. doi: 10.1177/0333102421999996. - DOI - PubMed
    1. Steiner T.J., Stovner L.J., Vos T. GBD 2015: Migraine is the third cause of disability in under 50s. J. Headache Pain. 2016;17:104. doi: 10.1186/s10194-016-0699-5. - DOI - PMC - PubMed
    1. Bigal M.E., Lipton R.B. Modifiable risk factors for migraine progression. Headache. 2006;46:1334–1343. doi: 10.1111/j.1526-4610.2006.00577.x. - DOI - PubMed
    1. Burch R.C., Buse D.C., Lipton R.B. Migraine: Epidemiology, Burden and Comorbidity. Neurol. Clin. 2019;37:631–649. doi: 10.1016/j.ncl.2019.06.001. - DOI - PubMed

MeSH terms